Studies by Nose and colleagues demonstrated that strong ERβ nuclear expression was implicated in the manifested EGFR mutations, in turn resulting in its favorable prognostic significance being influenced by EGFR mutations in lung adenocarcinoma patients [182]. This evidence concerns the gene EGFR and lung adenocarcinoma.